Introduction to ramps

Advances in Experimental Medicine and Biology

Volumn 744, Issue , 2012, Pages 1-11

  Parameswaran, Narayanan ^a   Spielman, William S ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; CALCIUM SENSING RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; RECEPTOR EXPRESSION ENHANCING PROTEIN; RECEPTOR TRANSPORTING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SURFACE; COMPLEX FORMATION; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; MODELS, ANIMAL; RECEPTOR ACTIVITY-MODIFYING PROTEINS; RECEPTORS, CALCIUM-SENSING;

EID: 84859792535     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2364-5_1     Document Type: Article

References (45)

1. McLatchie LM, Fraser NJ, Main MJ et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393(6683):333-339. (Pubitemid 28269699)
2. Fluhmann B, Muff R, Hunziker W et al. A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 1995; 206(1):341-347.
3. Aiyar N, Rand K, Elshourbagy NA et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996; 271(19):11325-11329. (Pubitemid 26155969)
4. Parameswaran N, Spielman WS. RAMPs: The past, present and future. Trends Biochem Sci 2006; 31(11):631-638. (Pubitemid 44635265)
5. Christopoulos A, Christopoulos G, Morfis M et al. Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 2003; 278(5):3293-3297. (Pubitemid 36801242)
6. Harikumar KG, Simms J, Christopoulos G et al. Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor. Biochemistry 2009; 48(49):11773-11785.
7. Bouschet T, Martin S, Henley JM. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 2005; 118(Pt 20):4709-4720. (Pubitemid 41646381)
8. ter Haar E, Koth CM, Abdul-Manan N et al. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 2010; 18(9):1083-1093.
9. Moore EL, Gingell JJ, Kane SA et al. Mapping the CGRP receptor ligand binding domain: Tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochem Biophys Res Commun 2010; 394(1):141-145.
10. Koth CM, Abdul-Manan N, Lepre CA et al. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor. Biochemistry 2010; 49(9):1862-1872.
11. Qi T, Simms J, Bailey RJ et al. Structure-function analysis of RAMP1-RAMP3 chimeras. Biochemistry 2010; 49(3):522-531.
12. Barwell J, Miller PS, Donnelly D et al. Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor. Peptides 2010; 31(1):170-176.
13. Chang CL, Park JI, Hsu SY. Activation of calcitonin receptor and calcitonin receptor-like receptor by membrane-anchored ligands. J Biol Chem 2010; 285(2):1075-1080.
14. Simms J, Hay DL, Bailey RJ et al. Structure-function analysis of RAMP1 by alanine mutagenesis. Biochemistry 2009; 48(1):198-205.
15. Conner AC, Simms J, Barwell J et al. Ligand binding and activation of the CGRP receptor. Biochem Soc Trans 2007; 35(Pt 4):729-732. (Pubitemid 47310355)
16. Conner AC, Simms J, Conner MT et al. Diverse functional motifs within the three intracellular loops of the CGRP1 receptor. Biochemistry 2006; 45(43):12976-12985. (Pubitemid 44763420)
17. Banerjee S, Evanson J, Harris E et al. Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding. BMC Pharmacol 2006; 6:9.
18. Simms J, Hay DL, Wheatley M et al. Characterization of the structure of RAMP1 by mutagenesis and molecular modeling. Biophys J 2006; 91(2):662-669.
19. Ittner LM, Koller D, Muff R et al. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. Biochemistry 2005; 44(15):5749-5754. (Pubitemid 40525111)
20. Ittner LM, Luessi F, Koller D et al. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2. Biochem Biophys Res Commun 2004; 319(4):1203-1209. (Pubitemid 38759538)
21. Steiner S, Born W, Fischer JA et al. The function of conserved cysteine residues in the extracellular domain of human receptor-activity-modifying protein. FEBS Lett 2003; 555(2):285-290. (Pubitemid 37486042)
22. Koller D, Born W, Leuthauser K et al. The extreme N-terminus of the calcitonin-like receptor contributes to the selective interaction with adrenomedullin or calcitonin gene-related peptide. FEBS Lett 2002; 531(3):464-468. (Pubitemid 35336070)
23. Miller PS, Barwell J, Poyner DR et al. Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74. Biochem Biophys Res Commun 2010; 391(1):437-442.
24. Salvatore CA, Mallee JJ, Bell IM et al. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor. Biochemistry 2006; 45(6):1881-1887. (Pubitemid 43222131)
25. Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: Biasing seven-transmembrane receptors. Nat Rev Drug Discov 2010; 9(5):373-386.
26. Reiter E, Lefkowitz RJ. GRKs and beta-arrestins: Roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 2006; 17(4):159-165.
27. Lefkowitz RJ, Rajagopal K, Whalen EJ. New roles for beta-arrestins in cell signaling: Not just for seven-transmembrane receptors. Mol Cell 2006; 24(5):643-652. (Pubitemid 44839219)
28. Cottrell GS, Padilla B, Pikios S et al. Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1. J Biol Chem 2007; 282(16):12260-12271. (Pubitemid 47100722)
29. Kuwasako K, Cao YN, Chu CP et al. Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of CGRP and adrenomedullin receptors. J Biol Chem 2006.
30. Bomberger JM, Spielman WS, Hall CS et al. Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1. J Biol Chem 2005; 280(25):23926-23935. (Pubitemid 40884881)
31. Bomberger JM, Parameswaran N, Hall CS et al. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking. J Biol Chem 2005; 280(10):9297-9307. (Pubitemid 40409622)
32. Hilairet S, Belanger C, Bertrand J et al. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1) and beta-arrestin. J Biol Chem 2001; 276(45):42182-42190.
33. Kuwasako K, Kitamura K, Nagata S et al. Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins. Biochem Biophys Res Commun 2009; 384(2):249-254.
34. Tsujikawa K, Yayama K, Hayashi T et al. Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci U S A 2007; 104(42):16702-16707. (Pubitemid 350211080)
35. Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest 2008; 118(1):29-39.
36. Fritz-Six KL, Dunworth WP, Li M et al. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 2008; 118(1):40-50.
37. Dackor R, Fritz-Six K, Smithies O et al. Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J Biol Chem 2007; 282(25):18094-18099. (Pubitemid 47100252)
38. 5Zhang Z, Winborn CS, Marquez de Prado B et al. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 2007; 27(10):2693-2703. (Pubitemid 46393588)
39. Tam CW, Husmann K, Clark NC et al. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circ Res 2005.
40. Saito H, Kubota M, Roberts RW et al. RTP family members induce functional expression of mammalian odorant receptors. Cell 2004; 119(5):679-691. (Pubitemid 39535755)
41. Bonner K, Kariyawasam HH, Ali FR et al. Expression of functional receptor activity modifying protein 1 by airway epithelial cells with dysregulation in asthma. J Allergy Clin Immunol 2010; 126(6):1277-1283, e1273.
42. Brekhman V, Lugassie J, Zaffryar-Eilot S et al. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2. FASEB J 2011; 25(1):55-65.
43. Chrissobolis S, Zhang Z, Kinzenbaw DA et al. Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke 2010; 41(10):2329-2334.
44. Sabharwal R, Zhang Z, Lu Y et al. Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension. Hypertension 2010; 55(3):627-635.
45. Husmann K, Sexton PM, Fischer JA et al. Mouse receptor-activity-modifying proteins 1, -2 and -3: Amino acid sequence, expression and function. Mol Cell Endocrinol 2000; 162(1-2):35-43. (Pubitemid 30347446)